Immunovant, Inc. (IMVT) Earnings
|
Expand Research on IMVT
| Next EPS Date | 8/6/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +6.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
6/3/26  |
Q426 | N/A | -$0.61 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/6/26 | Q326 | -$0.61 | -$0.72 | +$0.11 | N/A | N/A | N/A |  | | Details | |
| 11/10/25 | Q226 | -$0.73 | -$0.71 | -$0.02 | N/A | N/A | N/A | | | Details | |
| 8/11/25 | Q126 | -$0.71 | -$0.70 | -$0.01 | N/A | N/A | N/A | | | Details | |
| 8/6/25 |
Q126 | N/A | -$0.70 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/28/25 |
Q425 | N/A | -$0.71 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/12/25 |
Q325 | N/A | -$0.75 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/24 |
Q225 | N/A | -$0.59 | N/A | N/A | N/A | N/A | N/A | N/A |
